Engineers develop highly precise gene editor for safer cystic fibrosis treatments
Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic “base pairs” to a new level of precision
another news portal
Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic “base pairs” to a new level of precision
For more than six decades, biomarker-based newborn screening has played a pivotal role in reducing infant mortality and long-term disability by enabling early detection of
In a study of adults with cancer, those who developed a mental health condition within the first year after their cancer diagnosis had a higher
More than 60 million women in the U.S. live with cardiovascular disease
The medicines regulator is suggesting the minimum age limit for trial should be raised to 14.
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
BAFTA and the BBC have apologized after a person with Tourette syndrome shouted a racial slur during the British Academy Film Awards
Syndex Bio, a biotechnology company advancing next‑generation molecular diagnostics, today announced the introduction of its proprietary mcPCR™ (methyl‑copying PCR) platform at the Advances in Genome
Chronic GP shortages in England’s NHS reveal deep regional disparities, with current staffing levels failing to meet rising patient demand and safety standards.
Antimicrobial resistance poses a growing global health crisis, with few new antibiotics in development.
Chronic hypoxia improves glucose tolerance in mice through insulin-independent mechanisms, with red blood cells acting as a major systemic glucose sink. Increased erythrocyte production and
The tiny fatty capsules that delivered COVID-19 mRNA vaccines into billions of arms may work better when they’re a little disorganized.
Emma Dyer says she collapsed on her bathroom floor and began vomiting blood after buying jabs online.
Returning from my hiatus, I couldn’t decide on a specific new topic, mainly because so much bad stuff happened in my absence. So, in this